Bottlenecks in molecular testing for rare genetic diseases

Patrick J Willems1

  • 1Genetic Diagnostic Network (GENDIA), Antwerp, Belgium. willemspatrick@skynet.be

Human Mutation
|April 17, 2008
PubMed
Summary

Molecular diagnosis for rare genetic disorders remains slow and expensive, despite advances in genetic research. Addressing these bottlenecks is crucial to bridge the gap between genomic discovery and patient diagnosis.